AR and posterior cortical atrophy: Neuroendocrine prostate cancer (NEPC) is a highly aggressive form of prostate cancer (PCa), which is commonly characterized by typical neuroendocrine (NE) markers such as ENO2, SYP, and CHGA, but no or low levels of androgen receptor (AR) and AR-regulated genes [1, 2].